Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S; Immune Tolerance Network ITN057AD CATNIP Study Team. Corren J, et al. Among authors: moss mh. J Allergy Clin Immunol. 2023 Jan;151(1):192-201. doi: 10.1016/j.jaci.2022.08.029. Epub 2022 Oct 9. J Allergy Clin Immunol. 2023. PMID: 36223848 Clinical Trial.
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP. Corren J, et al. Among authors: moss mh. J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021. J Asthma Allergy. 2021. PMID: 34429614 Free PMC article.
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM. Szefler SJ, et al. Among authors: moss mh. J Allergy Clin Immunol. 2005 Feb;115(2):233-42. doi: 10.1016/j.jaci.2004.11.014. J Allergy Clin Immunol. 2005. PMID: 15696076 Clinical Trial.
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Sorkness CA, et al. Among authors: moss mh. J Allergy Clin Immunol. 2007 Jan;119(1):64-72. doi: 10.1016/j.jaci.2006.09.042. Epub 2006 Nov 30. J Allergy Clin Immunol. 2007. PMID: 17140647 Clinical Trial.
Immunotherapy: first do no harm.
Moss MH. Moss MH. Immunol Allergy Clin North Am. 2005 May;25(2):421-39, viii. doi: 10.1016/j.iac.2005.03.006. Immunol Allergy Clin North Am. 2005. PMID: 15878464 Review.
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF Jr, Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Zeiger RS, et al. Among authors: moss mh. J Allergy Clin Immunol. 2006 Jan;117(1):45-52. doi: 10.1016/j.jaci.2005.10.012. J Allergy Clin Immunol. 2006. PMID: 16387583 Clinical Trial.
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.
Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF Jr, Moss M, Szefler SJ, Krawiec M, Boehmer S, Mauger D, Taussig LM, Martinez FD; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Bacharier LB, et al. J Allergy Clin Immunol. 2009 May;123(5):1077-82, 1082.e1-5. doi: 10.1016/j.jaci.2008.12.1120. Epub 2009 Feb 23. J Allergy Clin Immunol. 2009. PMID: 19230959 Free PMC article.
Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.
Rabinovitch N, Graber NJ, Chinchilli VM, Sorkness CA, Zeiger RS, Strunk RC, Bacharier LB, Martinez FD, Szefler SJ; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Rabinovitch N, et al. J Allergy Clin Immunol. 2010 Sep;126(3):545-51.e1-4. doi: 10.1016/j.jaci.2010.07.008. J Allergy Clin Immunol. 2010. PMID: 20816189 Free PMC article. Clinical Trial.
Most nocturnal asthma symptoms occur outside of exacerbations and associate with morbidity.
Horner CC, Mauger D, Strunk RC, Graber NJ, Lemanske RF Jr, Sorkness CA, Szefler SJ, Zeiger RS, Taussig LM, Bacharier LB; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Horner CC, et al. J Allergy Clin Immunol. 2011 Nov;128(5):977-82.e1-2. doi: 10.1016/j.jaci.2011.07.018. Epub 2011 Sep 8. J Allergy Clin Immunol. 2011. PMID: 21855126 Free PMC article. Clinical Trial.
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y; Immune Tolerance Network Group. Casale TB, et al. Among authors: moss mh. J Allergy Clin Immunol. 2006 Jan;117(1):134-40. doi: 10.1016/j.jaci.2005.09.036. Epub 2005 Dec 2. J Allergy Clin Immunol. 2006. PMID: 16387596 Clinical Trial.
40 results